Welcome to LookChem.com Sign In|Join Free

CAS

  • or
L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]is a chemical compound derived from L-ornithine, an essential amino acid involved in protein biosynthesis. The addition of the N2-[(9H-fluoren-9-ylMethoxy)carbonyl] group enhances the stability and potential therapeutic effects of the molecule, making it a valuable compound for research and pharmaceutical applications.

158599-00-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (2S)-5-amino-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pentanoic acid

    Cas No: 158599-00-9

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 158599-00-9 Structure
  • Basic information

    1. Product Name: L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]-
    2. Synonyms: L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]-
    3. CAS NO:158599-00-9
    4. Molecular Formula: C20H22N2O4
    5. Molecular Weight: 354.39968
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 158599-00-9.mol
  • Chemical Properties

    1. Melting Point: 165.95 °C
    2. Boiling Point: 601.4±55.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.268±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 3.74±0.21(Predicted)
    10. CAS DataBase Reference: L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]-(CAS DataBase Reference)
    11. NIST Chemistry Reference: L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]-(158599-00-9)
    12. EPA Substance Registry System: L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]-(158599-00-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 158599-00-9(Hazardous Substances Data)

158599-00-9 Usage

Uses

Used in Pharmaceutical Research and Development:
L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]is used as a research compound for its potential therapeutic effects, particularly in promoting wound healing and tissue repair. The modified form of L-ornithine may contribute to the development of drugs for conditions such as liver disease and muscle atrophy.
Used in Medical Applications:
In the medical field, L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]is used as a potential therapeutic agent for promoting wound healing and tissue repair. Its ability to enhance the healing process makes it a valuable compound for treating various medical conditions that require tissue regeneration and repair.
Used in Drug Development for Liver Disease:
L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]is used as a potential drug candidate for the treatment of liver disease. Its therapeutic effects may help improve liver function and support the regeneration of liver tissue, offering a promising approach for managing liver-related conditions.
Used in Drug Development for Muscle Atrophy:
In the development of drugs for muscle atrophy, L-Ornithine, N2-[(9H-fluoren-9-ylMethoxy)carbonyl]is used as a potential therapeutic agent. Its ability to promote tissue repair and regeneration may help counteract the effects of muscle atrophy, providing a potential treatment option for conditions characterized by muscle wasting.

Check Digit Verification of cas no

The CAS Registry Mumber 158599-00-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,5,9 and 9 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 158599-00:
(8*1)+(7*5)+(6*8)+(5*5)+(4*9)+(3*9)+(2*0)+(1*0)=179
179 % 10 = 9
So 158599-00-9 is a valid CAS Registry Number.

158599-00-9Relevant articles and documents

Azide reduction during peptide cleavage from solid support - The choice of thioscavenger?

Schneggenburger, Philipp E.,Worbs, Brigitte,Diederichsen, Ulf

, p. 10 - 14 (2010)

Peptide azides acquired growing impact because of application in bioconjugation via 'click chemistry' or Staudinger ligation. Furthermore, there are many methods established in organic synthesis addressing the reduction of azides to amines, but no observation of a reductive transformation of peptide azides during SPPS cleavage was yet reported. In the present study, the reduction of peptide azides during SPPS cleavage was investigated depending on the choice of thioscavenger, reacting as reductive species. First observed for short PNA/peptide conjugates the occurring extensive side reaction was also validated for one of the applied azide amino acid building blocks and was further investigated by applying different cleavage cocktails to a series of peptides varying in hydrophobicity and position of the azide moiety in the oligomer sequence. Copyright

NOVEL CYCLIC PEPTIDES AND USES THEREOF

-

Page/Page column 76; 77, (2018/02/28)

Novel cyclic peptide GHRP-6 analogs of formula (I): (I) or pharmaceutically acceptable esters or salts thereof, are described. These cyclic peptide GHRP-6 analogs may be used for modulating CD36 activity, for example for the treatment of CD36-related dise

Strategy for "Detoxification" of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2

Brown, Zachary Z.,Müller, Manuel M.,Jain, Siddhant U.,Allis, C. David,Lewis, Peter W.,Muir, Tom W.

supporting information, p. 13498 - 13501 (2015/02/02)

The histone methyltransferase PRC2 plays a central role in genomic stability and cellular development. Consequently, its misregulation has been implicated in several cancers. Recent work has shown that a histone H3 mutant, where the PRC2 substrate residue Lys27 is replaced by methionine, is also associated with cancer phenotypes and functions as an inhibitor of PRC2. Here we investigate the mechanism of this PRC2 inhibition through kinetic studies and photo-cross-linking. Efficient inhibition is dependent on (1) hydrophobic lysine isosteres blocking the active site, (2) proximal residues, and (3) the H3 tail forming extensive contacts with the EZH2 subunit of PRC2. We further show that naturally occurring post-translational modifications of the same H3 tail, both proximal and distal to K27M, can greatly diminish the inhibition of PRC2. These results suggest that this potent gain of function mutation may be "detoxified by modulating alternate chromatin modification pathways.

Intramolecular cyclization assistance for fast degradation of ornithine-based poly(ester amide)s

De Gracia Lux, Caroline,Olejniczak, Jason,Fomina, Nadezda,Viger, Mathieu L.,Almutairi, Adah

, p. 3783 - 3790 (2013/09/02)

Inspired by the spontaneous cyclization of ornithine in peptides, polyesters containing protected ornithine (Orn) side chains along the backbone were synthesized and shown to degrade rapidly upon deprotection through intramolecular cyclization. A new ornithine-based poly(ester amide) PEA 1 and a lysine-based control PEA 2, both bearing the light-sensitive protecting group o-nitrobenzyl alcohol (ONB), were synthesized. Tert-butyl carbamate (Boc)-protected versions 1-Boc and 2-Boc were also synthesized for proof of concept. GPC confirmed that 1-Boc degrades over 40 times faster than 2-Boc following deprotection into the designed intramolecular cyclization products. Finally, TEM visualization of particles made from 1 encapsulating iron oxide nanoparticles reveals complete disruption of nanoparticles and release of payload within a day upon UV irradiation. Copyright

Use of p-nitrobenzyloxycarbonyl (pNZ) as a permanent protecting group in the synthesis of Kahalalide F analogs

López, Pilar E.,Isidro-Llobet, Albert,Gracia, Carolina,Cruz, Luis J.,García-Granados, Andrés,Parra, Andrés,álvarez, Mercedes,Albericio, Fernando

, p. 7737 - 7741 (2007/10/03)

p-Nitrobenzyloxycarbonyl (pNZ) is used for the permanent protection of ornithine in the synthesis of derivatives of the anti-tumor cyclodepsipeptide Kahalalide F that contain acid labile residues.

A novel fluorescence sensing system using a photochromism-based assay (P-CHROBA) technique for the detection of target proteins

Tomizaki, Kin-Ya,Mihara, Hisakazu

, p. 2732 - 2740 (2007/10/03)

In the post-genomic era a number of biological technologies, including protein-detecting microarrays which can detect molecular interactions based on changes in fluorescence intensity, have been developed to investigate complicated protein functions and n

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 158599-00-9